Deal Assures Market for Anemia Drug
Friday, November 18, 2011 - 13:10
in Mathematics & Economics
A dialysis chain has agreed to major purchases of the Amgen drug Epogen through 2018, helping the manufacturer to protect a lucrative business facing new competition.
